Lower eyelid position before and after blepharoptosis repair
Tatsuya Yunoki1, Mitsuya Otsuka1, Hitoshi Yamazaki1
1Departments of Ophthalmology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan.
Orbit (Amsterdam, Netherlands)
|December 15, 2023
Summary
Blepharoptosis surgery improved eyelid position, especially in patients with lower scleral show (LSS). Prostaglandin analogs (PGAs) use was linked to better outcomes in LSS patients after surgery.
Area of Science:
- Ophthalmology
- Surgical Outcomes
Background:
- Blepharoptosis surgery aims to correct eyelid drooping.
- Lower scleral show (LSS) is a potential complication or characteristic influencing surgical outcomes.
Purpose of the Study:
- To evaluate changes in lower eyelid position after blepharoptosis surgery.
- To identify factors influencing surgical outcomes, particularly in patients with LSS.
Main Methods:
- Retrospective study of 155 eyes from 89 patients undergoing blepharoptosis surgery.
- Comparison of margin reflex distance (MRD)-1 and MRD-2 pre- and post-operatively between LSS and non-LSS groups.
- Analysis of clinical characteristics and medication use, including prostaglandin analogs (PGAs).
Main Results:
- Both groups showed significant improvement in MRD-1 post-surgery.
- MRD-2 decreased significantly in the LSS group but remained stable in the non-LSS group.
- The LSS group had a higher prevalence of prostaglandin analog (PGA) use, which correlated with MRD-2 reduction.
Conclusions:
- Blepharoptosis surgery effectively improves eyelid position in patients with LSS.
- Prostaglandin analog (PGA) use may be associated with improved MRD-2 outcomes in patients with LSS after blepharoptosis surgery.
